Fisher Asset Management Portfolio holdings
Fisher Asset Management, LLC, operating as Fisher Investments, was founded in 1979 by Ken Fisher and is headquartered in Plano, Texas, following a relocation from Camas, Washington, in 2023. As an independent, fee-only investment adviser, it manages over $275 billion in assets for individual and institutional investors globally as of June 2024, offering tailored portfolio management through its Private Client Group and Institutional Group. Known for its active, top-down investment approach guided by a five-member Investment Policy Committee, the firm emphasizes asset allocation and has expanded internationally with offices in eight countries, including a wholly owned subsidiary, Fisher Investments Europe Limited, in London. With Ken Fisher as executive chairman and co-chief investment officer, succeeded as CEO by Damian Ornani in 2016, Fisher Investments blends a legacy of innovation with a client-first philosophy, recently spinning off its 401(k) Solutions into Fisher Retirement Solutions in 2024.
Top Buys
| 1 |
Lam Research
LRCX
|
$1.21B |
| 2 |
Sony
SONY
|
$778M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
$700M |
| 4 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
$344M |
| 5 |
NVIDIA
NVDA
|
$217M |
Top Sells
| 1 |
Expedia Group
EXPE
|
$142M |
| 2 |
Wynn Resorts
WYNN
|
$141M |
| 3 |
Blackrock
BLK
|
$135M |
| 4 |
Haleon
HLN
|
$126M |
| 5 |
Intuit
INTU
|
$116M |
Sector Composition
| 1 | Technology | 30.36% |
| 2 | Financials | 13.4% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 9.06% |
| 5 | Industrials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Nike
NKE
$110B
| $777M | 0.31% |
10,274,789
-28,393
| -0.3% | -$2.15M |
|
77
Trane Technologies
TT
$91.4B
| $747M | 0.3% |
2,022,151
-13,895
| -0.7% | -$5.13M |
|
78
Edwards Lifesciences
EW
$48B
| $724M | 0.29% |
9,775,276
+696,965
| +8% | +$51.6M |
|
79
AstraZeneca
AZN
$249B
| $718M | 0.29% |
10,959,852
+479,692
| +5% | +$31.4M |
|
80
Las Vegas Sands
LVS
$39.1B
| $709M | 0.28% |
13,810,351
+160,711
| +1% | +$8.25M |
|
81
BP
BP
$90.8B
| $690M | 0.27% |
23,340,485
+420,663
| +2% | +$12.4M |
|
82
iShares MSCI Europe Financials ETF
EUFN
$4.32B
| $660M | 0.26% |
28,313,803
-1,040,399
| -4% | -$24.2M |
|
83
GSK
GSK
$78.5B
| $637M | 0.25% |
18,836,797
+259,867
| +1% | +$8.79M |
|
84
Banco Santander
SAN
$140B
| $631M | 0.25% |
138,271,287
-5,313,865
| -4% | -$24.2M |
|
85
Ingersoll Rand
IR
$31B
| $617M | 0.25% |
6,825,518
+80,679
| +1% | +$7.3M |
|
86
iShares National Muni Bond ETF
MUB
$38.5B
| $612M | 0.24% |
5,745,654
+470,739
| +9% | +$50.2M |
|
87
Sanofi
SNY
$121B
| $603M | 0.24% |
12,511,027
-848,083
| -6% | -$40.9M |
|
88
PACCAR
PCAR
$51.9B
| $540M | 0.21% |
5,193,217
+12,292
| +0.2% | +$1.28M |
|
89
Applied Materials
AMAT
$126B
| $536M | 0.21% |
3,295,324
+40,581
| +1% | +$6.6M |
|
90
Boston Scientific
BSX
$158B
| $518M | 0.21% |
5,800,912
+1,028,977
| +22% | +$91.9M |
|
91
AB InBev
BUD
$120B
| $505M | 0.2% |
10,084,798
-222,216
| -2% | -$11.1M |
|
92
Medtronic
MDT
$120B
| $485M | 0.19% |
6,073,565
+179,845
| +3% | +$14.4M |
|
93
Alphabet (Google) Class C
GOOG
$2.56T
| $478M | 0.19% |
2,508,545
-80,406
| -3% | -$15.3M |
|
94
Banco Bilbao Vizcaya Argentaria
BBVA
$104B
| $474M | 0.19% |
48,799,680
-2,155,096
| -4% | -$20.9M |
|
95
Crown Castle
CCI
$42.7B
| $474M | 0.19% |
5,218,431
+130,414
| +3% | +$11.8M |
|
96
iShares Global Healthcare ETF
IXJ
$3.82B
| $463M | 0.18% |
5,382,479
+198,778
| +4% | +$17.1M |
|
97
Alibaba
BABA
$330B
| $432M | 0.17% |
5,093,828
+78,757
| +2% | +$6.68M |
|
98
Coca-Cola
KO
$297B
| $412M | 0.16% |
6,619,580
-146,089
| -2% | -$9.1M |
|
99
iShares Global Tech ETF
IXN
$5.65B
| $406M | 0.16% |
4,795,150
-133,236
| -3% | -$11.3M |
|
100
iShares Global Energy ETF
IXC
$1.86B
| $387M | 0.15% |
10,131,253
+298,815
| +3% | +$11.4M |
|